Kisunla for Alzheimer’s Now 40% Safer
July 10, 2025
Why Did Europe Finally Choose Lecanemab for Alzheimer’s?
Europe originally said Lecanemab (Brand-name Leqembi) was too risky to approve. Now they are recommending marketing it. Why the change of heart? (Video)
Source:
Related:
Ensuring Lecanemab Reaches Those Who Need It
June 5, 2025
Best Time to Stop Medicine for Dementia
May 29, 2025
Lecanemab’s Rare and Manageable Side Effects
May 23, 2025
How Many People Take Leqembi?
May 5, 2025
Email me when people comment
Login
0 Comments
Edited by:
Peter Berger
With experience in dementia caregiving, public education, and Alzheimer’s-focused writing—and a professional research background shaped in what many consider one of the world’s top laboratories—I work to make complex findings clear, practical, and genuinely helpful for families and professionals providing care.
Welcome. About this Site.
This site was inspired by my Mom’s autoimmune dementia.
It is a place where we separate out the wheat from the chafe, the important articles & videos from each week’s river of news. Google gets a new post on Alzheimer’s or dementia every 7 minutes. That can overwhelm anyone looking for help. This site filters out, focuses on and offers only the best information. it has helped hundreds of thousands of people since it debuted in 2007. Thanks to our many subscribers for your supportive feedback.
The site is dedicated to all those preserving the dignity of the community of people living with dementia.
Peter Berger, Editor
Share this page To
Dementia Books & Videos on Amazon:
More From Alzheimer's Weekly
Drugs
Leqembi Injection, an Easier Alzheimer’s Treatment, Awaits FDA Approval
LEQEMBI® is the newest Alzheimer’s drug. It is administered in hospitals via IV. Biogen applied to the FDA for approval of a home version using an “Autoinjector”. See how it works and learn its advantages.
No Comments
Clinical Trials
Spectris™ Headset: Treat Alzheimer’s with Gamma Waves
See why Cognito’s headset received FDA Breakthrough Device Designation for addressing cognitive and functional symptoms associated with Alzheimer’s.
4 Comments
Prevention
Living in Awe Can Lower Alzheimer’s
Researchers discovered AWE to be a potent predictor of reduced pro-inflammatory cytokines. Can the awe we feel when touched by the beauty of nature, art and spirituality protect us from Alzheimer’s high levels of cytokines?
No Comments
Clinical Trials
Neuropsychological Test Beats MRI at Tracking Dementia
Doctors routinely diagnose and track dementia. “Neuropsychological tests” are non-invasive, using interviews or paper/pen tests. More invasive diagnostics include powerful MRI and PET scans.
No Comments
Share to Facebook
Twitter
LinkedIn
Welcome. About this Site.
This site was inspired by my Mom’s autoimmune dementia.
It is a place where we separate out the wheat from the chafe, the important articles & videos from each week’s river of news. Google gets a new post on Alzheimer’s or dementia every 7 minutes. That can overwhelm anyone looking for help. This site filters out, focuses on and offers only the best information. it has helped hundreds of thousands of people since it debuted in 2007. Thanks to our many subscribers for your supportive feedback.
The site is dedicated to all those preserving the dignity of the community of people living with dementia.
Peter Berger, Editor
Visit Alzheimer's Weekly On